Overview This page contains the latest trade data of Antibiotics nes, formulated, in bulk. In 2023, Antibiotics nes, formulated, in bulk were the world's 2143rd most traded product, with a total trade of $973M. Between 2022 and 2023 the exports of Antibiotics nes, formulated, in bulk decreased by -11.5%, from $1.1B to $973M. Trade in Antibiotics nes, formulated, in bulk represent 0.0043% of total world trade.
Antibiotics nes, formulated, in bulk are a part of Unpackaged Medicaments.
Exports In 2023 the top exporters of Antibiotics nes, formulated, in bulk were China ($287M), Japan ($140M), Italy ($137M), Jordan ($129M), and India ($34.2M).
Imports In 2023 the top importers of Antibiotics nes, formulated, in bulk were Netherlands ($135M), Switzerland ($101M), Saudi Arabia ($84.7M), United Arab Emirates ($52.6M), and United States ($42.7M).
Ranking Antibiotics nes, formulated, in bulk ranks 2694th in the Product Complexity Index (PCI).
Description Antibiotics are largely used to treat bacterial infections in humans and animals. They are usually prescribed when a bacterial infection cannot be treated effectively by other means. Antibiotics can be administered in the form of pills, capsules, or liquids. They can also be administered through an intravenous drip.